151 related articles for article (PubMed ID: 26103703)
21. Longitudinal study of cervical squamous intraepithelial lesions in human immunodeficiency virus (HIV)-seropositive and at-risk HIV-seronegative women.
Schuman P; Ohmit SE; Klein RS; Duerr A; Cu-Uvin S; Jamieson DJ; Anderson J; Shah KV;
J Infect Dis; 2003 Jul; 188(1):128-36. PubMed ID: 12825181
[TBL] [Abstract][Full Text] [Related]
22. Prevalence of abnormal anal cytology and high-grade squamous intraepithelial lesions among a cohort of HIV-infected men who have sex with men.
Sendagorta E; Herranz P; Guadalajara H; Bernardino JI; Viguer JM; Beato MJ; García-Olmo D; Peña JM
Dis Colon Rectum; 2014 Apr; 57(4):475-81. PubMed ID: 24608304
[TBL] [Abstract][Full Text] [Related]
23. CD4 T-LYMPHOCYTE SUBSETS IN WOMEN WITH INVASIVE CERVICAL CANCER IN KENYA.
Gichangi P; Gathece L; Estambale B; Temmerman M
East Afr Med J; 2013 Oct; 90(10):309-15. PubMed ID: 26862640
[TBL] [Abstract][Full Text] [Related]
24. High prevalence of oncogenic human papillomavirus in the genital tract of women with human immunodeficiency virus.
Volkow P; Rubí S; Lizano M; Carrillo A; Vilar-Compte D; García-Carrancá A; Sotelo R; García B; Sierra-Madero J; Mohar A
Gynecol Oncol; 2001 Jul; 82(1):27-31. PubMed ID: 11426958
[TBL] [Abstract][Full Text] [Related]
25. Prevalence of cervical squamous intraepithelial lesions among HIV-positive women in Enugu, South-eastern Nigeria.
Dim CC; Ezegwui HU; Ikeme AC; Nwagha UI; Onyedum CC
J Obstet Gynaecol; 2011 Nov; 31(8):759-62. PubMed ID: 22085071
[TBL] [Abstract][Full Text] [Related]
26. Pre-vaccination prevalence of infections with 25 non-high-risk human papillomavirus types among 1,000 Slovenian women in cervical cancer screening.
Učakar V; Poljak M; Oštrbenk A; Klavs I
J Med Virol; 2014 Oct; 86(10):1772-9. PubMed ID: 24978445
[TBL] [Abstract][Full Text] [Related]
27. HIV and cervical cancer in Kenya.
Gichangi P; De Vuyst H; Estambale B; Rogo K; Bwayo J; Temmerman M
Int J Gynaecol Obstet; 2002 Jan; 76(1):55-63. PubMed ID: 11818095
[TBL] [Abstract][Full Text] [Related]
28. Squamous intraepithelial lesions (SILs) and HPV associated changes in HIV infected women or at risk of HIV. DIANAIDS Cooperative Study Group.
Branca M; Migliore G; Giuliani MLeoncini L; Ippolito G; Cappiello G; Garbuglia AR; Schiesari A; Rezza G
Eur J Gynaecol Oncol; 2000; 21(2):155-9. PubMed ID: 10843475
[TBL] [Abstract][Full Text] [Related]
29. Highly active antiretroviral therapy and incidence of cervical squamous intraepithelial lesions among HIV-infected women with normal cytology and CD4 counts above 350 cells/mm3.
Sirera G; Videla S; López-Blázquez R; Llatjos M; Tarrats A; Castellà E; Grane N; Tural C; Rey-Joly C; Clotet B
J Antimicrob Chemother; 2008 Jan; 61(1):191-4. PubMed ID: 17977910
[TBL] [Abstract][Full Text] [Related]
30. The association between HIV infection, antiretroviral therapy and cervical squamous intraepithelial lesions in South Western Nigerian women.
Ezechi OC; Pettersson KO; Okolo CA; Ujah IA; Ostergren PO
PLoS One; 2014; 9(5):e97150. PubMed ID: 24809726
[TBL] [Abstract][Full Text] [Related]
31. Cervical neoplastic lesions in relation to CD4 T-lymphocyte counts and antiretroviral therapy among women with clinical stage 1 HIV in Yunnan, China.
Zhang DY; Chen W; Zhang HY; Lv SQ; Lu XN; Tao YP; Zhang M; Liu JF; Yang M; Qiao YL; Braithwaite D
Kaohsiung J Med Sci; 2020 Jun; 36(6):450-459. PubMed ID: 31913555
[TBL] [Abstract][Full Text] [Related]
32. Malignancies in women with HIV infection.
Krishnan A; Levine AM
Womens Health (Lond); 2008 Jul; 4(4):357-68. PubMed ID: 19072501
[TBL] [Abstract][Full Text] [Related]
33. Influence of adherent and effective antiretroviral therapy use on human papillomavirus infection and squamous intraepithelial lesions in human immunodeficiency virus-positive women.
Minkoff H; Zhong Y; Burk RD; Palefsky JM; Xue X; Watts DH; Levine AM; Wright RL; Colie C; D'Souza G; Massad LS; Strickler HD
J Infect Dis; 2010 Mar; 201(5):681-90. PubMed ID: 20105077
[TBL] [Abstract][Full Text] [Related]
34. Cervical screening in HIV-positive women in the East of England: recent CD4 as the predictive risk factor.
Davies O; Rajamanoharan S; Balachandran T
Int J STD AIDS; 2015 Nov; 26(13):945-50. PubMed ID: 25505037
[TBL] [Abstract][Full Text] [Related]
35. Prevalence and severity of cervical squamous intraepithelial lesion in a tertiary hospital in northern Tanzania.
Obure J; Olola O; Swai B; Mlay P; Masenga G; Walmer D
Tanzan J Health Res; 2009 Oct; 11(4):163-9. PubMed ID: 20734694
[TBL] [Abstract][Full Text] [Related]
36. Risk factors for cervical precancer detection among previously unscreened HIV-infected women in Western Kenya.
Huchko MJ; Leslie H; Sneden J; Maloba M; Abdulrahim N; Bukusi EA; Cohen CR
Int J Cancer; 2014 Feb; 134(3):740-5. PubMed ID: 23900762
[TBL] [Abstract][Full Text] [Related]
37. Effect of highly active antiretroviral therapy (HAART) and menopause on risk of progression of cervical dysplasia in human immune-deficiency virus- (HIV-) infected women.
Kim SC; Messing S; Shah K; Luque AE
Infect Dis Obstet Gynecol; 2013; 2013():784718. PubMed ID: 24453469
[TBL] [Abstract][Full Text] [Related]
38. Screening for cervical carcinoma in HIV-infected women: Analysis of main risk factors for cervical cytologic abnormalities.
Sansone M; Saccone G; Migliucci A; Saviano R; Capone A; Maruotti GM; Bruzzese D; Martinelli P
J Obstet Gynaecol Res; 2017 Feb; 43(2):352-357. PubMed ID: 28026078
[TBL] [Abstract][Full Text] [Related]
39. Cervical squamous intraepithelial lesions among HIV-positive women on antiretroviral therapy in Kenya.
McKenzie KP; Rogers RK; Njoroge JW; John-Stewart G; Richardson BA; Mugo NR; De Vuyst H; Pamnani RN; Rana FS; Warui D; Chung MH
Curr HIV Res; 2011 Apr; 9(3):180-5. PubMed ID: 21585334
[TBL] [Abstract][Full Text] [Related]
40. Low uptake of cervical cancer screening among HIV positive women in Gondar University referral hospital, Northwest Ethiopia: cross-sectional study design.
Nega AD; Woldetsadik MA; Gelagay AA
BMC Womens Health; 2018 Jun; 18(1):87. PubMed ID: 29879969
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
